Bionet (1784) — Strategic Asset Allocation Index
Bionet (1784) has a Strategic Asset Allocation Index of 37.2% as of June 2023. Strategic assets (PP&E of NT$502.40 Million plus long-term investments of NT$-) total NT$502.40 Million, measured against net assets of NT$1.35 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Bionet Strategic Asset Allocation Index (2017–2021)
This chart shows how Bionet's Strategic Asset Allocation Index has evolved across 5 annual periods from 2017 to 2021. As of June 2023, the index stands at 37.2%, representing strategic assets of NT$502.40 Million against net assets of NT$1.35 Billion TWD. Explore Bionet (1784) cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Bionet (2017–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Bionet from 2017 to 2021, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see 1784 company net worth.
| Year | SAAI | Strategic Assets (TWD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 39.2% | NT$515.20 Million | NT$515.20 Million | NT$- | NT$1.32 Billion | ▼ -1.2 pp |
| 2020 | 40.4% | NT$520.69 Million | NT$520.69 Million | NT$- | NT$1.29 Billion | ▲ +0.2 pp |
| 2019 | 40.2% | NT$525.30 Million | NT$525.30 Million | NT$- | NT$1.31 Billion | ▲ +1.2 pp |
| 2018 | 39.0% | NT$522.95 Million | NT$522.95 Million | NT$- | NT$1.34 Billion | ▲ +0.1 pp |
| 2017 | 39.0% | NT$534.50 Million | NT$534.50 Million | NT$- | NT$1.37 Billion | — |